Search Results - "Vereecken, Jens"

Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system by Rupasinghe, Praharshinie, Driesen, Michele, Vereecken, Jens, de Jong, Bouke, Rigouts, Leen

“…Background: Fluoroquinolones (FQs) have substantial activity against the Mycobacterium tuberculosis complex (MTBc) by preventing bacterial DNA synthesis…”
Get full text

Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid by Rupasinghe, Praharshinie, Reenaers, Rabab, Vereecken, Jens, Mulders, Wim, Cogneau, Sari, Merker, Matthias, Niemann, Stefan, Vally Omar, Shaheed, Rigouts, Leen, Köser, Claudio U, Decroo, Tom, de Jong, Bouke C

“…Previous work reported unprecedented differences in the intrinsic susceptibility of the complex (MTBC) to pretomanid (Pa) using the Mycobacteria Growth…”
Get full text

Middlebrook 7h11 reduces invalid results and turnaround time of phenotypic drug-susceptibility testing of M. tuberculosis by Rupasinghe, Praharshinie, Vereecken, Jens, Graulus, Pieter, Decroo, Tom, Ardizzoni, Elisa, Hewison, Cathy, Donchuk, Dimitri, Huerga, Helena, Mesic, Anita, Rigouts, Leen, de Jong, Bouke

“…Background: Phenotypic drug-susceptibility testing (pDST), which relies on growth inhibition in the drug-containing media, remains a challenge for fastidious…”
Get full text